S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Stock market today: Asian benchmarks trade mixed amid expectations for US rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities

DexCom (DXCM) Earnings Date, Estimates & Call Transcripts

$136.52
+1.96 (+1.46%)
(As of 04/16/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 25
After Market Closes
Confirmed
Actual EPS
(Feb. 8)
$0.50 Beat By $0.07
Consensus EPS
(Feb. 8)
$0.43
Skip Charts & View Estimated and Actual Earnings Data

DXCM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DXCM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

DexCom Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.25$0.33$0.28 
Q2 20243$0.34$0.47$0.40 
Q3 20243$0.39$0.53$0.47 
Q4 20243$0.42$0.53$0.48 
FY 202412$1.40$1.86$1.64 
Q1 20252$0.37$0.37$0.37 
Q2 20252$0.47$0.53$0.50 
Q3 20251$0.67$0.67$0.67 
Q4 20251$0.69$0.69$0.69 
FY 20256$2.20$2.26 $2.23

DXCM Earnings Date and Information

DexCom last announced its quarterly earnings results on February 8th, 2024. The medical device company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.07. The firm earned $1.03 billion during the quarter, compared to the consensus estimate of $1.02 billion. Its quarterly revenue was up 26.9% on a year-over-year basis. DexCom has generated $1.31 earnings per share over the last year ($1.31 diluted earnings per share) and currently has a price-to-earnings ratio of 104.2. Earnings for DexCom are expected to grow by 26.70% in the coming year, from $1.76 to $2.23 per share. DexCom has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024. DexCom will be holding an earnings conference call on Thursday, April 25th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

DexCom Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/25/2024
Confirmed)
-------  
2/8/2024Q4 2023$0.43$0.50+$0.07$0.38$1.02 billion$1.03 billion      
10/26/2023Q3 2023$0.34$0.50+$0.16$0.71$939.64 million$975.00 million      
7/27/2023Q2 2023$0.22$0.34+$0.12$0.40$841.16 million$871.30 million      
4/27/2023Q1 2023$0.15$0.17+$0.02$0.22$720.52 million$7.45 billion    
2/9/2023Q4 2022$0.26$0.34+$0.08$0.46$814.52 million$815.20 million      
10/27/2022Q3 2022$0.24$0.28+$0.04$0.32$752.67 million$769.60 million
7/28/2022Q2 2022$0.17$0.17-$0.22$709.33 million$696.20 million    
4/28/2022Q1 2022$0.1250$0.08($0.0450)($0.29)$623.97 million$628.80 million      
2/10/2022Q4 2021$0.2150$0.17($0.0450)$1.56$698.66 million$698.20 million    
10/28/2021Q3 2021$0.1550$0.2225+$0.0675$1.07$617.07 million$650.20 million    
7/29/2021Q2 2021$0.1075$0.19+$0.0825$0.89$548.02 million$595.10 million      
4/29/2021Q1 2021$0.0775$0.0825+$0.0050$0.25$482.67 million$505.00 million    

DexCom Earnings - Frequently Asked Questions

When is DexCom's earnings date?

DexCom has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on DXCM's earnings history.

Did DexCom beat their earnings estimates last quarter?

In the previous quarter, DexCom (NASDAQ:DXCM) reported $0.50 earnings per share (EPS) to beat the analysts' consensus estimate of $0.43 by $0.07. Learn more on analysts' earnings estimate vs. DXCM's actual earnings.

How can I listen to DexCom's earnings conference call?

The conference call for DexCom's latest earnings report can be listened to online. Listen to Conference Call

How can I read DexCom's conference call transcript?

The conference call transcript for DexCom's latest earnings report can be read online. Read Transcript

How can I view DexCom's earnings report?

DexCom's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does DexCom generate each year?

DexCom (NASDAQ:DXCM) has a recorded annual revenue of $3.62 billion.

How much profit does DexCom generate each year?

DexCom (NASDAQ:DXCM) has a recorded net income of $541.50 million. DXCM has generated $1.31 earnings per share over the last four quarters.

What is DexCom's price-to-earnings ratio?

DexCom (NASDAQ:DXCM) has a trailing price-to-earnings ratio of 104.21 and a forward price-to-earnings ratio of 77.57. The price/earnings-to-growth ratio is 2.34.

What is DexCom's EPS forecast for next year?

DexCom's earnings are expected to grow from $1.76 per share to $2.23 per share in the next year, which is a 26.70% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:DXCM) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners